Harbor Capital Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $417K | Buy |
20,399
+3,804
| +23% | +$77.8K | 0.02% | 547 |
|
|
2025
Q1 | $332K | Sell |
16,595
-101,905
| -86% | -$2.04M | 0.02% | 574 |
|
|
2024
Q4 | $3.16M | Sell |
118,500
-35,407
| -23% | -$944K | 0.14% | 207 |
|
|
2024
Q3 | $4.39M | Buy |
153,907
+15,200
| +11% | +$433K | 0.19% | 163 |
|
|
2024
Q2 | $3.02M | Buy |
138,707
+99,001
| +249% | +$2.16M | 0.23% | 127 |
|
|
2024
Q1 | $879K | Buy |
39,706
+27,754
| +232% | +$614K | 0.11% | 246 |
|
|
2023
Q4 | $258K | Buy |
11,952
+2,205
| +23% | +$47.6K | 0.05% | 334 |
|
|
2023
Q3 | $165K | Sell |
9,747
-4,517
| -32% | -$76.3K | 0.04% | 370 |
|
|
2023
Q2 | $196K | Buy |
+14,264
| New | +$196K | 0.04% | 366 |
|